(Q71727512)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8892461%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8892461%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

J P Lamond

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8892461%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

M Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8892461%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

T J Kinsella

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8892461%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

D A Boothman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8892461%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

language of work or name

English

0 references

publication date

1 September 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8892461%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8892461%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8892461%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8892461%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

361-368

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8892461%20AND%20SRC:MED&resulttype=core&format=json

Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks

20 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900328-8

7 January 2021

Anticarcinogenic potential of DNA-repair modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900328-8

7 January 2021

Interaction of topoisomerase I inhibitors with radiation in cis-diamminedichloroplatinum(II)-sensitive and -resistant cells in vitro and in the FSAIIC fibrosarcoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900328-8

7 January 2021

Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900328-8

7 January 2021

Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900328-8

7 January 2021

DNA damaging and cell cycle effects of the topoisomerase I poison camptothecin in irradiated human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900328-8

7 January 2021

DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900328-8

7 January 2021

On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900328-8

7 January 2021

Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900328-8

7 January 2021

Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900328-8

7 January 2021

The inhibition of cellular recovery in human tumour cells by inhibitors of topoisomerase

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900328-8

7 January 2021

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900328-8

7 January 2021

The current status of camptothecin analogues as antitumor agents

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900328-8

7 January 2021

Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900328-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900328-8

1 reference

7 January 2021

10.1016/S0360-3016(96)00328-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8892461%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference